IL150918A0 - Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production - Google Patents
Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum productionInfo
- Publication number
- IL150918A0 IL150918A0 IL15091802A IL15091802A IL150918A0 IL 150918 A0 IL150918 A0 IL 150918A0 IL 15091802 A IL15091802 A IL 15091802A IL 15091802 A IL15091802 A IL 15091802A IL 150918 A0 IL150918 A0 IL 150918A0
- Authority
- IL
- Israel
- Prior art keywords
- ester
- sebum production
- dual inhibitors
- inhibiting sebum
- synthesis
- Prior art date
Links
- 239000004164 Wax ester Substances 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- -1 cholesteryl ester Chemical class 0.000 title 1
- 230000009977 dual effect Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 210000002374 sebum Anatomy 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
- 235000019386 wax ester Nutrition 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30933601P | 2001-08-01 | 2001-08-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL150918A0 true IL150918A0 (en) | 2003-02-12 |
Family
ID=23197778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL15091802A IL150918A0 (en) | 2001-08-01 | 2002-07-25 | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20030134898A1 (forum.php) |
| EP (1) | EP1281399A3 (forum.php) |
| JP (1) | JP2003104878A (forum.php) |
| KR (1) | KR20030013289A (forum.php) |
| CN (1) | CN1404829A (forum.php) |
| CA (1) | CA2395006A1 (forum.php) |
| HU (1) | HUP0202548A2 (forum.php) |
| IL (1) | IL150918A0 (forum.php) |
| NZ (1) | NZ520487A (forum.php) |
| PL (1) | PL355281A1 (forum.php) |
| ZA (1) | ZA200206032B (forum.php) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7279576B2 (en) | 2002-12-31 | 2007-10-09 | Deciphera Pharmaceuticals, Llc | Anti-cancer medicaments |
| US7202257B2 (en) | 2003-12-24 | 2007-04-10 | Deciphera Pharmaceuticals, Llc | Anti-inflammatory medicaments |
| US7144911B2 (en) | 2002-12-31 | 2006-12-05 | Deciphera Pharmaceuticals Llc | Anti-inflammatory medicaments |
| CN1863521B (zh) * | 2003-10-09 | 2012-01-25 | 沃尼尔·朗伯有限责任公司 | 用于减少皮脂产生的包含丙二酰胺衍生物的药物组合物 |
| US20070078121A1 (en) | 2004-12-23 | 2007-04-05 | Flynn Daniel L | Enzyme modulators and treatments |
| US8188113B2 (en) | 2006-09-14 | 2012-05-29 | Deciphera Pharmaceuticals, Inc. | Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| US7790756B2 (en) | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| US20080261961A1 (en) | 2007-04-20 | 2008-10-23 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoprolific diseases and other proliferative diseases |
| CA2742007C (en) | 2008-10-29 | 2014-07-08 | Deciphera Pharmaceuticals, Llc | Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| US8461179B1 (en) | 2012-06-07 | 2013-06-11 | Deciphera Pharmaceuticals, Llc | Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases |
| MA44225A (fr) | 2016-02-16 | 2018-12-26 | The Provost Fellows Found Scholars And The Other Members Of Board Of The College Of The Holy & Undiv | Sulfonylurées et composés apparentés et leur utilisation |
| GB201721185D0 (en) | 2017-12-18 | 2018-01-31 | Nodthera Ltd | Sulphonyl urea derivatives |
| CA3089630A1 (en) | 2018-01-31 | 2019-08-08 | Deciphera Pharmaceuticals, Llc | Combination therapy for the treatment of mastocytosis |
| AU2019215081B2 (en) | 2018-01-31 | 2024-07-25 | Deciphera Pharmaceuticals, Llc. | Combination therapy for the treatment of gastrointestinal stromal tumors |
| CR20210139A (es) * | 2018-08-15 | 2021-06-24 | Inflazome Ltd | Compuestos de sulfonamidaurea novedosos |
| FI3983387T3 (fi) | 2019-06-12 | 2024-07-09 | Nodthera Ltd | Sulfonyyliureajohdannaisia ja niiden käyttötarkoituksia |
| CA3150433A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
| WO2021030405A1 (en) | 2019-08-12 | 2021-02-18 | Deciphera Pharmaceuticals, Llc | Ripretinib for treating gastrointestinal stromal tumors |
| CA3163053A1 (en) | 2019-12-30 | 2021-07-08 | Michael D. Kaufman | Amorphous kinase inhibitor formulations and methods of use thereof |
| FI4084779T3 (fi) | 2019-12-30 | 2024-12-16 | Deciphera Pharmaceuticals Llc | 1-(4-bromi-5-(1-etyyli-7-(metyyliamino)-2-okso-1,2-dihydro-1,6-naftyridin-3-yyli)-2-fluorifenyyli)-3-fenyyliurean koostumuksia |
| US11779572B1 (en) | 2022-09-02 | 2023-10-10 | Deciphera Pharmaceuticals, Llc | Methods of treating gastrointestinal stromal tumors |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4716175A (en) * | 1987-02-24 | 1987-12-29 | Warner-Lambert Company | Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase |
| US5245068A (en) * | 1990-10-30 | 1993-09-14 | Warner-Lambert Company | Oxysulfonyl carbamates |
| US5254715A (en) * | 1990-11-07 | 1993-10-19 | Warner-Lambert Company | Aminosulfonyl carbamates |
| US5214206A (en) * | 1990-11-07 | 1993-05-25 | Warner-Lambert Company | Aminosulfonyl urea acat inhibitors |
| US5198466A (en) * | 1990-11-09 | 1993-03-30 | Warner-Lambert Company | Oxysulfonyl urea acat inhibitors |
| ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
| IL109431A (en) * | 1993-05-14 | 2001-01-11 | Warner Lambert Co | Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds |
| US5491172A (en) * | 1993-05-14 | 1996-02-13 | Warner-Lambert Company | N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| US6133326A (en) * | 1994-08-31 | 2000-10-17 | Pfizer Inc | Compositions and methods for decreasing sebum production |
| JP2003531113A (ja) * | 2000-02-02 | 2003-10-21 | ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー | 皮脂腺障害のためのコレステロールエステルとワックスエステルの合成の二重阻害剤 |
| US6514489B1 (en) * | 2000-06-30 | 2003-02-04 | Medicis Pharmaceutical Corp. | Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| WO2002060388A2 (en) * | 2001-01-30 | 2002-08-08 | Merck & Co., Inc. | Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
-
2002
- 2002-07-23 EP EP02255156A patent/EP1281399A3/en not_active Withdrawn
- 2002-07-25 IL IL15091802A patent/IL150918A0/xx unknown
- 2002-07-25 CA CA002395006A patent/CA2395006A1/en not_active Abandoned
- 2002-07-29 ZA ZA200206032A patent/ZA200206032B/xx unknown
- 2002-07-31 PL PL02355281A patent/PL355281A1/xx not_active Application Discontinuation
- 2002-07-31 HU HU0202548A patent/HUP0202548A2/hu unknown
- 2002-07-31 CN CN02127403A patent/CN1404829A/zh active Pending
- 2002-07-31 JP JP2002222616A patent/JP2003104878A/ja active Pending
- 2002-07-31 NZ NZ520487A patent/NZ520487A/en unknown
- 2002-07-31 KR KR1020020045396A patent/KR20030013289A/ko not_active Ceased
- 2002-07-31 US US10/209,236 patent/US20030134898A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2003104878A (ja) | 2003-04-09 |
| EP1281399A2 (en) | 2003-02-05 |
| HUP0202548A2 (hu) | 2003-02-28 |
| NZ520487A (en) | 2004-03-26 |
| CA2395006A1 (en) | 2003-02-01 |
| ZA200206032B (en) | 2004-02-10 |
| CN1404829A (zh) | 2003-03-26 |
| HU0202548D0 (forum.php) | 2002-10-28 |
| PL355281A1 (en) | 2003-02-10 |
| EP1281399A3 (en) | 2004-02-11 |
| KR20030013289A (ko) | 2003-02-14 |
| US20030134898A1 (en) | 2003-07-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL150918A0 (en) | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production | |
| HUP0300497A3 (en) | Inhibitors of human phosphatidyl-inositol 3-kinase delta | |
| EP1383743A4 (en) | DOUBLE INHIBITORS OF PDE 7 AND PDE 4 | |
| IL163277A (en) | Controlled synthesis of ziprasidone and compositions thereof | |
| IL154017A0 (en) | Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors | |
| IL163863A0 (en) | Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz | |
| IL158765A0 (en) | Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors | |
| AU2002305205A1 (en) | 9-deazaguanine derivatives as inhibitors of gsk-3 | |
| DE60127098D1 (de) | Inhibitoren der mucin-synthese | |
| EP1549316A4 (en) | HAMMER OF TFGbeta | |
| AU2002346548A8 (en) | Regioisomerically pure oxochlorins and methods of synthesis | |
| AU2002213422A1 (en) | Synthesis of 2-hydroxymethylglutamic acid and congeners thereof | |
| GB0220861D0 (en) | Presentation of information | |
| DZ3288A1 (en) | Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders | |
| HUP0401641A3 (en) | Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors | |
| AU2252101A (en) | New synthesis of SPLA2 inhibitors | |
| GB2375762B (en) | Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters | |
| AU2002300319A1 (en) | Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production | |
| AU2050001A (en) | Synthesis of indole-containing spla2 inhibitors | |
| AU2001257253A1 (en) | Asymmetric synthesis of piperazic acid and derivatives thereof | |
| IL161608A0 (en) | Synthesis of 2-aralkoxyadenosines and 2-alkoxyadenosines | |
| PL375437A1 (en) | Synthesis of gatifloxacin | |
| PL1611083T3 (pl) | Synteza estrów kwasu 2-chlorometylo-6-metylobenzoesowego | |
| GB0225106D0 (en) | Synthesis of 3 hydroxy-5 -steroids | |
| AU2003299746A1 (en) | Total synthesis of daurichromenic acid |